How to form technological capabilities in the mining companies of biopharmaceutical companies

Developing new capabilities is a complex process that involves continuous learning of technology and organizational knowledge. In the past, researchers have proposed a learning hierarchy model to explain the development ability of companies in developing countries. It has also been suggested that these companies compete on the basis of the production capabilities of a simple knowledge base. Rough ideas about sequences and steps, especially at the company level, can be misleading. The learning processes that underlie knowledge accumulation and development require technical capabilities as well as organizational knowledge management. An important aspect of this learning involves discarding competencies that may have been useful in previous courses but have not been introduced to new environments. The link between experience and production is still needed but not enough to develop innovative capabilities. Therefore, learning at the company level is neither automatic nor linear, but requires deliberate investment in various learning mechanisms. In the case of biopharmaceutical companies, due to the advanced nature of this type of industry, it was found that companies need a diverse set of learning mechanisms and the performance and implementation of a diverse set of learning processes, plays a key role in the accumulation of technological capabilities. In these industries, companies need a consistent strategy to manage and organize a diverse set of learning processes. The learning process is also affected by the absorber capacity. At the same time, the development of biotechnology is carried out by government-sponsored research and development programs.